Scientists in Uruguay have found genotypes of the human papillomavirus (HPV) linked to cervical cancer in urban wastewater, ...

A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to find out if the shot also prevents heart attacks ...

Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

The Human Papillomavirus (HPV) is a common virus that spreads through skin-to-skin contact, particularly during sexual ...

DHAKA, May 25, 2025 (BSS) - The rate of cervical cancer infection is highest among women aged 35 to 39 while main cause of ...

The Human Papilloma Virus Testing Market is set to grow from USD 1.76 Billion in 2024 to USD 3.72 Billion by 2030, driven by a 13.60% CAGR. Rising screenings, at-home testing kits, and technological ...

This was revealed at a national event held at the Shaheed Abu Sayeed Convention Center of BMU on Sunday when key findings from a nationwide cervical and breast cancer screening programme incorporating ...

A new study has found alarmingly low awareness and uptake of the Human Papillomavirus (HPV) vaccine among rural women in Uganda’s Busoga Sub-region, despite high public willingness to vaccinate ...

The wand developed by Teal Health allows patients to self-collect a vaginal sample and mail it to a lab for testing.

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

Teal Health has made an at-home test that screens for human papillomavirus (HPV), the virus that causes nearly all cervical cancers.